The Levitronix CentriMag is approved in Europe for 30 days as uni- or biventricular support in acute heart failure as a bridge to recovery, bridge to heart transplantation or to a long-term left ventricular assist device (LVAD). We report the case of a patient who was supported with the same Levitronix CentriMag pump for 119 days without changing any components of the circuit or the pump head because of an anatomical condition which precluded the feasibility of pump exchange and who did not experience any mechanical failure of the impeller but eventually died due to the rupture of the cannulae. This is the first report of failure of paracorporeal short-term LVAD due to disruption of one cannula with a properly functioning pump.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/jocs.12149 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of mobilization in patients with short-term mechanical circulatory support such as Levitronix® CentriMag as a bridge to heart transplantation.
Enferm Intensiva (Engl Ed)
March 2023
Institut de Recerca del Hospital Vall d'Hebron, Servicio de Cardiología del Hospital Universitari Vall d'Hebron, Barcelona, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares (CIBERCV), Spain.
Introduction: Despite the benefits of mobilisation in the critical patient, the evidence in patients with Levitronix® CentriMag as a bridge to heart transplantation (HT) is scarce. The objective of this study is to analyze the impact of mobility on these patients.
Methods: Retrospective observational study of patients who received a HT with Levitronix® CentriMag admitted between 2010 and 2019 to a tertiary hospital.
Trends in contemporary advanced heart failure management: an in-depth review over 30 years of heart transplant service in Hong Kong.
Korean J Transplant
December 2022
Department of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong.
Article Synopsis
- The study reviews the trends and outcomes of advanced heart failure (AHF) and heart transplants in Hong Kong over the past 30 years, marking the 30th anniversary of heart transplant services in the region.
- Data from 1993 to 2021 shows an increasing prevalence of AHF, correlating with rising clinic referrals and utilization of mechanical circulatory support devices, particularly venoarterial ECMO.
- Survival rates for heart transplant recipients and those receiving durable left ventricular assist devices (LVADs) are comparable, highlighting improvements in AHF management despite the growing complexity of patient needs.
Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.
Transplant Proc
November 2021
Heart Failure and Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain; Department of Cardiology, La Fe University and Polytechnic Hospital, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; Universidad de Valencia, Valencia, Spain.
Background: The purpose of the study was to analyze postcardiac transplant complications in patients who received transplants with short-term mechanical ventricular assist devices and to compare complications according to the type of device.
Methods: Ambispective and consecutive study of urgent heart transplants from 2015 to 2019. Pediatric transplants, retransplants, and combined transplants were excluded.
Analysis of the Intrahospital and Long-Term Survival of Heart Transplant Patients With a Short-Term Mechanical Assistance Device.
Transplant Proc
November 2021
Heart Failure and Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain; Department of Cardiology, La Fe University and Polytechnic Hospital, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; University of Valencia, Valencia, Spain.
Background: The purpose of this study was to compare early and late survival among patients who have undergone heart transplantation (HTx) with a short-term mechanical assist device.
Methods: This was an ambispective, single-center, consecutive study of patients undergoing urgent HTx for 5 years. Pediatric transplants, retransplants, and combined transplants were excluded.
Temporary biventricular support as a bridge to recovery: A justifiable strategy for small children with fulminant myocarditis.
Perfusion
July 2022
Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.
Short-term mechanical circulatory support can be life-saving in the pediatric population with acute cardiogenic shock (ACS). However, recovery from MCS is a rare entity. MCS options are limited for low-body-weight children in Turkey.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!